Cost-effectiveness of sex-neutral HPV vaccination in Sweden, accounting for herd immunity and sexual behaviour
The aim was to assess cost-effectiveness of expanding the Swedish HPV-vaccination program to include preadolescent boys, by comparing health effects and costs of HPV-related disease, with a sex-neutral vaccination program versus only vaccinating girls.
Provides students with a list of credible online resources about immunization.
Des stratégies potentielles pour améliorer les taux de vaccination infantile au Canada : Document de principes de la SCP
Les taux de vaccination sont sous-optimaux au Canada. Certains pays utilisent des stratégies comme des preuves de vaccination obligatoires pour entrer à la garderie ou à l’école et des incitations financières. D’autres stratégies pourraient fonctionner dans le contexte canadien, telles que la remise, à l’entrée à l’école, d’un dossier de tous les vaccins administrés, la création de registres de vaccination provinciaux ou territoriaux, l’information aux parents et aux enfants d’âge scolaire au sujet des maladies évitables par la vaccination et l’adoption de mesures afin que les parents puissent s’assurer plus facilement de la vaccination complète de leurs enfants.
Effectiveness of a hospital-based postnatal parent education intervention about pain management during infant vaccination: a randomized controlled trial
Parents have reported that they want to learn how to reduce pain in infants during vaccinations. The objective was to compare different levels of intensity of postnatal education about pain mitigation on parental self-reported use of interventions at future infant vaccinations. Hospital-based postnatal education increased parental use of pain interventions at infant vaccinations and can be added to existing education.
The objective of the current work is to give evidence to the importance of spreading the culture of prevention of infectious diseases in an ageing society at different levels, and to address possible strategies to reach high vaccination coverage in adulthood, giving an accent on the correct managing of adult vaccination programmes and communication skills.
Chapter in the Canadian Immunization Guide revised in August 2018.
Human papillomavirus (HPV) is known to cause genital warts, cervical cancer, penile cancer, anal cancer and oropharyngeal cancer. In North America, the lifetime cumulative incidence of HPV infection is estimated at more than 70% for all HPV types combined. A safe and effective vaccine against nine HPV types is available. HPV vaccine should be administered routinely to all girls and boys between the ages of 9 and 13 years of age. All youth who have not received the vaccine in a routine program should receive the vaccine in a ‘catch-up’ program. Physicians caring for children and youth should advocate for funding and implementation of universal HPV vaccine programs.
It’s been decades since Canada was first declared polio-free. Within the tremendous victory this represents for vaccines and immunization there is, however, a hidden danger.